Full Press Release Details
Sciences, a Subsidiary of BioTime, Signs Definitive Distribution
Agreement with ProSpec-Tany TechnoGene
ALAMEDA, Calif.--(BUSINESS WIRE)--November 20, 2012--LifeMap Sciences,
Inc. a subsidiary of BioTime, Inc. (NYSE MKT: BTX) announced today that
it has signed a definitive distribution agreement with ProSpec-Tany
TechnoGene Ltd. (ProSpec). In the beginning of 2013, LifeMap Sciences
will be offering more than a 1000 recombinant proteins and antibodies,
many of which are related to stem cell research, such as growth factors,
signaling molecules, differentiation factors, hormones, cytokines and
chemokines. LifeMap Sciences is the principal marketing and sales arm
for BioTime's cell-based products and related reagents for research use
in academia, research hospitals, and biotech and pharma companies.
ProSpec's innovative products will complement the current BioTime
research product lines available via the recently launched LifeMap
BioReagents portal, including PureStem human
progenitor cell lines, PureStem packages, clinical and research
grade human embryonic stem cell lines (hES), HyStem
hydrogels, culture media, and cell differentiation kits.
LifeMap BioReagents offering of BioTime products and the
upcoming addition of the ProSpec products reflects the company's initial
execution of a strategy to market a growing catalog of research products
to aid scientists in a variety of fields, including stem cell research,
developmental biology, mechanisms of various human diseases, drug
discovery, and therapeutic discovery and development. LifeMap Sciences
holds the exclusive, worldwide license to market GeneCards
(www.genecards.org), with over 12 million page visits per
year from hundreds of thousands of unique users worldwide, and MalaCards
(www.malacards.org), and plans to launch LifeMap
Discovery , its database for biomedical and stem cell
research, later this quarter. LifeMap BioReagents will be
integrated with the GeneCards , MalaCards,
and LifeMap Discovery databases, thereby providing
hundreds of thousands of biomedical researchers accessing these
databases a means of identifying reagents that can enhance their
research and discovery efforts.
These databases currently feature targeted links to the various BioTime PureStem
human progenitor cell lines, PureStem packages, and clinical and
research grade human embryonic stem cell lines, and will soon add links
to the ProSpec manufactured products. These links enable researchers who
access the databases to become familiar with, and purchase, products
that relate directly to the types of genes, cells, or diseases that they
are studying and can assist them in various research projects.
"We are pleased to establish this distribution relationship with
ProSpec," stated Yaron Guan-Golan, Head of Marketing at LifeMap
Sciences. "This agreement represents a significant step for our LifeMap
BioReagents portal, enabling us to place high quality recombinant
proteins in the hands of our research community user base, and
increasing our product portfolio and brand awareness."
About LifeMap Sciences, Inc.
LifeMap Sciences' (www.lifemapsc.com) core technology and
business is based on its integrated database suite, the discovery
platform for biomedical and stem cell research. This platform includes GeneCards ,
the leading human gene database; LifeMap Discovery , the
database of embryonic development, stem cell research, and regenerative
medicine; and MalaCards, the human disease database. LifeMap
Sciences also markets PanDaTox, an innovative, recently
developed, searchable database that can aid in the discovery of new
antibiotics and biotechnologically beneficial products.
In addition to database offerings, LifeMap Sciences is BioTime's
principal marketing subsidiary for research products, including PureStem
human progenitor cell lines, GMP human embryonic stem (hES) cell lines, ESpan
growth media for progenitor cell lines, and cell differentiation media
for non-therapeutic uses, via its LifeMap BioReagents
portal. LifeMap Sciences will utilize its databases as part of its
online marketing strategy to reach life sciences researchers at biotech
and pharmaceutical companies and at academic institutions and research
hospitals worldwide.
In a therapeutic discovery collaboration with BioTime, LifeMap's
scientists utilize LifeMap's proprietary platform, including LifeMap
Discovery , its stem cell database along with the GeneCards
and MalaCards integrated database suite, to aid in the
development of BioTime's proprietary PureStem human
progenitor cell lines into products for the treatment of human diseases,
especially degenerative diseases that might be treatable with cell
replacement therapies. The LifeMap Discovery platform will
be used to select the progenitor cell lines that are most likely to
facilitate the development of cell-based regenerative medicine therapies
for a wide range of diseases.
About ProSpec-Tany TechnoGene Ltd.
ProSpec (Protein-Specialists) is a leading biotechnology company having
over 19 years of experience specializing in production of
bacterial-derived recombinant proteins. ProSpec produces a wide array of
Cytokines, Growth Factors, Chemokines, Hormones, Enzymes, Viral Antigens
and many other recombinant proteins.
ProSpec's proprietary protein purification technologies with over a
decade of extensive experience result in low production costs, high
yield, production efficiency, utmost pure products and uncompromising
biological activity at competitive prices. ProSpec provides custom
in-house production services of recombinant proteins tailored to the
ProSpec provides proteins, services and technology license to a broad
range of customers around the globe from academic and government
research institutions, biotechnology and pharmaceutical companies, as
well as hospitals and reference laboratories.
ProSpec's goal is to supply proteins which are crucial to the research
industry to meet and exceed quality, consistency and requirements by our
customers worldwide. The company welcomes partnerships with
pharmaceutical and industrial companies for development of future
BioTime, headquartered in Alameda, California, is a biotechnology
company focused on regenerative medicine and blood plasma volume
expanders. Its broad platform of stem cell technologies is enhanced